Sanofi (SNY) News Today $51.98 -2.64 (-4.83%) Closing price 04:00 PM EasternExtended Trading$51.46 -0.52 (-1.01%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Wellington Management Group LLP Has $216.28 Million Holdings in Sanofi (NASDAQ:SNY)Wellington Management Group LLP trimmed its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 3.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,484,318 shares of the company's stock after selApril 4 at 4:34 AM | marketbeat.comClearbridge Investments LLC Has $11.90 Million Stake in Sanofi (NASDAQ:SNY)Clearbridge Investments LLC reduced its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 8.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 246,711 shares of the company's stock after selling 23,129 sApril 4 at 4:32 AM | marketbeat.comJPMorgan Chase & Co. Trims Stock Position in Sanofi (NASDAQ:SNY)JPMorgan Chase & Co. decreased its stake in Sanofi (NASDAQ:SNY - Free Report) by 6.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,156,275 shares of the company's stock after selling 154,534 sApril 4 at 3:46 AM | marketbeat.comWhy Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?April 3 at 12:40 PM | benzinga.comLamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On ThursdayApril 3 at 10:20 AM | benzinga.comFranklin Resources Inc. Buys 369,530 Shares of Sanofi (NASDAQ:SNY)Franklin Resources Inc. boosted its position in Sanofi (NASDAQ:SNY - Free Report) by 10.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,776,982 shares of the company's stock after acquiring anApril 3 at 5:27 AM | marketbeat.comO Shaughnessy Asset Management LLC Sells 16,977 Shares of Sanofi (NASDAQ:SNY)O Shaughnessy Asset Management LLC trimmed its position in Sanofi (NASDAQ:SNY - Free Report) by 12.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 115,257 shares of the company's stock after selling 1April 3 at 4:56 AM | marketbeat.comPress Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicinesApril 3 at 1:00 AM | globenewswire.comIs Sanofi (SNY)the Best Gene-Editing Stock to Buy?April 3 at 12:18 AM | finance.yahoo.comSanofi treatment of immunoglobulin G4-related disease granted orphan statusApril 2 at 10:30 AM | markets.businessinsider.comSanofi’s Dupixent Gains Approval in Japan for COPD TreatmentApril 2 at 7:20 AM | tipranks.comLeerink Partnrs Issues Positive Outlook for Sanofi EarningsSanofi (NASDAQ:SNY - Free Report) - Equities research analysts at Leerink Partnrs lifted their Q1 2025 earnings per share estimates for Sanofi in a research note issued to investors on Sunday, March 30th. Leerink Partnrs analyst D. Risinger now forecasts that the company will post earnings of $0.April 2 at 6:28 AM | marketbeat.comSanofi India Secures Court Approval for Export Rebate ClaimApril 2 at 5:52 AM | tipranks.comSanofi (NASDAQ:SNY) Holdings Raised by Orion Portfolio Solutions LLCOrion Portfolio Solutions LLC increased its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 10.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 71,179 shares of the company's stock after purchasing an addApril 1 at 4:47 AM | marketbeat.comPictet Asset Management Holding SA Sells 55,700 Shares of Sanofi (NASDAQ:SNY)Pictet Asset Management Holding SA lowered its holdings in Sanofi (NASDAQ:SNY - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 733,291 shares of the company's stocApril 1 at 4:32 AM | marketbeat.comFDA Approves Sanofi's Hemophilia DrugMarch 31, 2025 | benzinga.comSanofi (NASDAQ:SNY) Shares Sold by Barrow Hanley Mewhinney & Strauss LLCBarrow Hanley Mewhinney & Strauss LLC lowered its holdings in Sanofi (NASDAQ:SNY - Free Report) by 1.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,697,289 shares of the company's stock after selling 140,540 shaMarch 31, 2025 | marketbeat.com7,840 Shares in Sanofi (NASDAQ:SNY) Acquired by Congress Wealth Management LLC DECongress Wealth Management LLC DE acquired a new stake in Sanofi (NASDAQ:SNY - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 7,840 shares of the company's stock, valued at approximately $378,000. Several other largMarch 31, 2025 | marketbeat.comSanofi Consumer Healthcare India Limited Announces Postal Ballot ResultsMarch 30, 2025 | tipranks.comFDA approves Sanofi treatment for hemophilia A or BMarch 28, 2025 | markets.businessinsider.comFDA Approves Sanofi's (SNY) Qfitlia for Hemophilia TreatmentMarch 28, 2025 | gurufocus.comFDA approves Sanofi’s hemophilia treatment QfitliaMarch 28, 2025 | in.investing.comRegeneron, Sanofi announce Dupixent authorization in JapanMarch 28, 2025 | markets.businessinsider.comPress Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitorsMarch 28, 2025 | globenewswire.comUS FDA approves Sanofi's bleeding disorder therapyMarch 28, 2025 | reuters.comRegeneron (NASDAQ:REGN) and Sanofi Get Japan Green Light for Smokers’ Lung Disease TreatmentMarch 28, 2025 | tipranks.comLPL Financial LLC Buys 142,290 Shares of Sanofi (NASDAQ:SNY)LPL Financial LLC lifted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 12.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,284,096 shares of the company's stock after purchasing an additional 142,290 shares during theMarch 28, 2025 | marketbeat.comPress Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDMarch 28, 2025 | globenewswire.comSanofi’s Tolebrutinib and Chlamydia Vaccine Achieve Regulatory MilestonesMarch 26, 2025 | tipranks.comZions Bancorporation N.A. Raises Stock Holdings in Sanofi (NASDAQ:SNY)Zions Bancorporation N.A. boosted its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 165,350 shares of the company's stock after acquiring an additional 10,990 shares during the qMarch 26, 2025 | marketbeat.comSei Investments Co. Raises Holdings in Sanofi (NASDAQ:SNY)Sei Investments Co. lifted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 8.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 644,302 shares of the company's stock after purchasing an additional 47,801 sharesMarch 26, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Receives Average Rating of "Buy" from BrokeragesMarch 26, 2025 | americanbankingnews.comPress Release: Chlamydia vaccine candidate granted fast track designation by the US FDAMarch 26, 2025 | globenewswire.comSanofi reports tolebrutinib submission accepted for FDA priority reviewMarch 25, 2025 | markets.businessinsider.comCantor Fitzgerald calls attention to Alnylam’s Amvuttra’s 30% royalty burdenMarch 25, 2025 | markets.businessinsider.comSanofi gets priority review for its multiple sclerosis treatment by FDAMarch 25, 2025 | msn.comSanofi (NASDAQ:SNY) Shares Acquired by American Century Companies Inc.American Century Companies Inc. boosted its position in Sanofi (NASDAQ:SNY - Free Report) by 1.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,707,057 shares of the company's stock after purchasing an additional 2March 25, 2025 | marketbeat.comPress Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisMarch 25, 2025 | globenewswire.comSimplify Asset Management Inc. Cuts Stock Position in Sanofi (NASDAQ:SNY)Simplify Asset Management Inc. decreased its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 80.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,387 shares of the company's stock afteMarch 24, 2025 | marketbeat.comGuardian Partners Inc. Invests $9.16 Million in Sanofi (NASDAQ:SNY)Guardian Partners Inc. acquired a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 186,109 shares of the company's stock, valued at approximately $9,162,000. Other hedge funds have also aMarch 24, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Shares Bought by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. grew its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 8.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 151,945 shares of the company's stock aMarch 24, 2025 | marketbeat.comPress Release: Availability of the Q1 2025 Aide mémoireMarch 24, 2025 | globenewswire.comTD Private Client Wealth LLC Reduces Stock Position in Sanofi (NASDAQ:SNY)TD Private Client Wealth LLC lowered its stake in Sanofi (NASDAQ:SNY - Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 93,033 shares of the company's stock after selling 8,763 shares during the quarter.March 23, 2025 | marketbeat.comCorient Private Wealth LLC Sells 5,152 Shares of Sanofi (NASDAQ:SNY)Corient Private Wealth LLC reduced its stake in Sanofi (NASDAQ:SNY - Free Report) by 5.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 98,296 shares of the company's stock after selling 5,152 shares during the period.March 23, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Coverage Initiated at The Goldman Sachs GroupThe Goldman Sachs Group started coverage on Sanofi in a report on Friday. They set a "neutral" rating and a $65.00 target price for the company.March 22, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Receives Average Recommendation of "Buy" from AnalystsSanofi (NASDAQ:SNY - Get Free Report) has been given an average recommendation of "Buy" by the four brokerages that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, one has issued a buy recommendation and two have given a strMarch 22, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of Sanofi - Depositary Receipt () (SNY) with Neutral RecommendationMarch 21, 2025 | msn.comBanks launch $8.1B debt sale, finance stake in Sanofi unit, Bloomberg saysMarch 21, 2025 | markets.businessinsider.comSanofi initiated with a Neutral at Goldman SachsMarch 21, 2025 | markets.businessinsider.comSanofi to acquire Dren Bio’s DR-0201; deal includes $600M upfront paymentMarch 21, 2025 | markets.businessinsider.com Remove Ads Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼1.080.61▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼2414▲SNY Articles Average Week Remove Ads Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News NVS News GSK News TAK News ARGX News ONC News BNTX News TEVA News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
